- Eisai Co., Ltd. and Biogen Inc. announced today that humanized anti- soluble aggregated amyloid-beta monoclonal antibody LEQEMBI has been approved in China as a treatment of mild cognitive.
Story of former prisoner of war Jack Cox from Sedgeford told by daughter Diane more than 80 years later in new book lynnnews.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lynnnews.co.uk Daily Mail and Mail on Sunday newspapers.
Biogen Inc.: Centralized Marketing Authorizations of Generic Versions of TECFIDERA® are Revoked by the European Commission finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Friedreich’s ataxia is a genetic, debilitating and life-shortening neuromuscular disease1Milestone highlights Biogen’s growing portfolio in rare diseases.